Safety and immunogenicity of the BNT162b2 mRNA Covid-19 vaccine in patients with chronic lymphocytic leukemia: a prospective study

Introduction: Immunization of patients with chronic lymphocytic leukemia (CLL) with vaccines against several infectious diseases has proven insufficient. Data on seroconversion of patients with CLL after vaccination against severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) are still young...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Panagiotis T. Diamantopoulos, Christos Stafylidis, Dimitra Vlachopoulou, Christina-Nefeli Kontandreopoulou, Nefeli Giannakopoulou, Maria Vardaka, Anthi Mpouhla, Elpida Mastrogianni, Eleni Variami, Athanasios Galanopoulos, Vasiliki Pappa, Mina Psichogiou, Angelos Hatzakis, Nora-Athina Viniou
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	SAGE Publishing 2022-05-01
Edice:	Therapeutic Advances in Hematology
On-line přístup:	https://doi.org/10.1177/20406207221090150
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!